Celyad Grants To Novartis AG A Non-Exclusive License For Its Allogeneic TCR-Deficient CAR-T Cells Patents – biolegacy

Celyad Grants To Novartis AG A Non-Exclusive License For Its Allogeneic TCR-Deficient CAR-T Cells Patents

Post author:Sam
Post published:May 1, 2017
Post category:BioPharma

Life Sciences Jobs …
Source: BioSpace